CSL, BrightInsight launch Hemgenix companion app

CSL Behring's recently approved gene therapy for haemophilia B Hemgenix has joined the swelling ranks of new medicines that are bundled with a companion app to support the

How digital is transforming the commercial leader’s role in ...

Pharma’s evolving role in patient care

Digital tools key to immuno-oncology’s future: report

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down.

AstraZeneca’s digital health alliance with BrightInsight bea...

AstraZeneca has launched a digital toolkit for people living with chronic health conditions, a year after it started working with digital health specialist BrightInsight on the project.

CSL, BrightInsight team up on digital health for rare diseas...

CSL Behring has signed a deal with US firm BrightInsight to develop digital health products to help patients with rare diseases manage their conditions.

AstraZeneca forges alliance with digital health firm BrightI...